News
Rising oil prices have investors buying Vanguard Energy ETF, but Chevron might be the better choice for long-term investors.
Via The Motley Fool · April 1, 2026
Compelling valuations and a tailwind from the eventual end of the Iran war makes this group intriguing.
Via The Motley Fool · April 1, 2026
The S&P 500 index yields 1.1%, but this high-yield variant yields 4%.
Via The Motley Fool · April 1, 2026
Vanguard FTSE Canadian High Dividend Yield Index ETF (TSX:VDY) stands out as a great bet if you're not ready to buy big on tech.
Via The Motley Fool · March 31, 2026
Via Benzinga · March 31, 2026
The global semiconductor market staged a dramatic recovery on March 31, 2026, as investors aggressively bought the dip following a punishing two-week sell-off. The iShares Semiconductor ETF (Nasdaq: SOXX) surged 4%, marking its strongest single-day performance of the year and reclaiming critical technical support levels. This rebound serves as a
Via MarketMinute · March 31, 2026
The fixed income market experienced a decisive shift on March 31, 2026, as Treasury yields tumbled across the curve. The benchmark 10-year Treasury note, a critical barometer for global borrowing costs, fell to 4.22% from a morning high of 4.31%. This move reflects a complex realignment of investor
Via MarketMinute · March 31, 2026
These two reliable ETFs are easily some of the top funds that Canadian investors can buy for compelling passive income in 2026.
Via The Motley Fool · March 31, 2026
This ultra‑lean dividend ETF delivers monthly payouts from the top 21 of Canada’s highest‑quality dividend stocks -- tax‑free inside your TFSA.
Via The Motley Fool · March 31, 2026
Via Benzinga · March 31, 2026
Via Benzinga · March 31, 2026
Warren Buffett says he will not buy Apple right now despite long-term confidence, bringing to the spotlight a passive ETF investing risk.
Via Benzinga · March 31, 2026
Long-term investors should be gearing up to buy stocks on a dip.
Via The Motley Fool · March 31, 2026
GLD is a prime candidate for a collar — owning the shares, buying a protective put, and selling a covered call.
Via Barchart.com · March 31, 2026
Investing in exchange-traded funds (ETFs) can be a great way to minimize risk while also putting you in an excellent position to grow your portfolio over the long term.
Via The Motley Fool · March 31, 2026
Sen. Elizabeth Warren warns Trump's Fed stance could spark inflation, reviving Richard Nixon-era fears and putting inflation-focused ETFs in the spotlight.
Via Benzinga · March 31, 2026

RTX Corp (NYSE: RTX) jumps 2.4% on a new defense contract. Analysis of 12-month gains, RSI neutral signals, and top ETF exposure.
Via Benzinga · March 31, 2026
The Industrial Select Sector SPDR ETF fell 10% in March — the worst month since September 2022. Here's what happened the other 11 times, and which stocks got hit hardest.
Via Benzinga · March 31, 2026
The concept of all-weather investing is appealing during times of stress.
Via The Motley Fool · March 31, 2026
It might not be flashy, but it is stable.
Via The Motley Fool · March 31, 2026
Ark Invest added to three existing positions that have plunged at least 49% form their 52-week highs.
Via The Motley Fool · March 31, 2026
Semiconductor bear ETFs saw a brief surge, but quickly gave up gains as chip stocks rebound due to dip-buying, relief in broader sentiment, short covering and a technical bounce.
Via Benzinga · March 31, 2026
When the market breaks down, I look for stocks that are dancing to the beat of their own drum. These three are strong contenders. Here's what to know.
Via Barchart.com · March 31, 2026
Via MarketBeat · March 31, 2026
In a month characterized by macroeconomic headwinds and a broader cooling of the biotechnology sector, Corcept Therapeutics (NASDAQ: CORT) has emerged as a definitive outlier. While the S&P Biotech ETF (NYSEARCA: XBI) and the Nasdaq Biotechnology Index (NASDAQ: IBB) struggled to find their footing in late March 2026, dropping
Via MarketMinute · March 31, 2026